Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
24.10 23.37 20.54 23.19

+8 more quarters

P/S ratio
2.48 2.36 2.03 2.43
P/FCF ratio
22.22 18.70 13.53 18.67
P/Operating CF
116.54 72.34 58.55 46.13
P/B ratio
7.66 7.39 6.09 6.29
EV/Sales
2.55 2.40 2.06 2.45
EV/EBITDA
15.47 15.00 13.31 15.34
EV/FCF
22.87 19.02 13.74 18.75
Current Ratio
1.11 0.91 0.85 1.05
Net Debt/EBITDA
1.65 0.94 0.73 (0.64)
Debt/Equity
0.27 0.17 0.11 0.00
Earnings Yield
4.15% 4.28% 4.87% 4.31%
Free Cash Flow Yield
4.50% 5.35% 7.39% 5.36%
Free Cash Flow per Share
2.91 5.28 5.21 8.20
Book value per Share
65.97 63.04 62.01 68.02
Free Cash Flow
37.94 69.58 71.24 118.00
EV/EBIT
18.30 17.87 15.99 18.30
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026